Bringing you live news and features since 2006 

Horizons ETFs to launch first marijuana ETF

RELATED TOPICS​

Horizons ETFs Management has filed its final prospectus to launch the Horizons Medical Marijuana Life Sciences ETF (HMMJ).

Units of the exchange traded fund (ETF) have been conditionally approved for listing by the Toronto Stock Exchange (TSX) and are slated to begin trading on 5 April 2017, under the ticker symbol HMMJ.
 
HMMJ will be the first ETF that offers direct exposure to North American-listed stocks that are involved with medical marijuana bioengineering and production.
 
HMMJ is a passively managed ETF which seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index (the Index), net of expenses. The index is designed to provide exposure to the performance of a basket of North American publicly traded companies with significant business activities in the marijuana industry.
 
"The medical marijuana industry is rapidly growing in North America as legislators allow or consider allowing more legal uses of marijuana and marijuana-related products, particularly medical marijuana usage," says Steve Hawkins, president and co-CEO of Horizons ETFs. "HMMJ is a way for investors to directly access the medical marijuana and life sciences industry through a transparent, low-cost ETF that holds a diversified basket of companies."
 
The North American Medical Marijuana Index is designed to be a liquid and investable index of equity securities of publicly listed life sciences companies, and other firms, with business activities in the marijuana industry. The index selects from a current universe of publicly-listed North American companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses to the marijuana industry.
Only stocks that meet minimum asset and liquidity thresholds are eligible for inclusion in the index.
 
Stocks in the index are rebalanced quarterly on a market-capitalisation basis, and capped so that no single stock can exceed 10 per cent of the weight of the index when rebalanced.
 
"Given the recent high returns generated by medical marijuana companies, investors are clearly attracted to the industry," says Hawkins. "We feel that the methodology of the North American Medical Marijuana Index will maximise the risk/reward opportunity for investors by ensuring the companies in the index meet important liquidity and asset requirements, so that the stocks in the index are the leaders in the medical marijuana industry."

Latest News

HSBC Asset Management’s (HSBC AM) ETF and Indexing business has passed USD100 billion in assets under management (AUM), reflecting its..
Amundi’s ETF Market Flows Analysis for April reveals that investors added EUR54.1 billion to global ETFs in April with equities..
VanEck has reached USD10 billion in assets under management in Europe for the first time in April 2024...
Global index revenues increased 9.3 per cent in 2023, totalling a record USD5.8 billion, according to a benchmark study published..

Related Articles

Dan Miller, IQ-EQ
With just over a week to go till T+1 settlement begins in North America, Canada and Mexico, time is of...
Emily Spurling, Nasdaq
Last October’s ETF Express US Awards 2023 found Nasdaq winning Best Index Provider – ESG ETFs and Best Index Provider...
Vinit Srivistava, MerQube
Index provider, MerQube, launched in 2019, with the aim of providing a “technology-driven answer to the most complex, rules-based investment...
Sean O' Hara
Pacer ETFs has announced the launch of three Cash Cows UCITS ETFs. The firm writes that this will give European...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by